Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBE Vaccination in Allergic Patients
NCT02511535Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2013
- Primary completion
- Feb 2016
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Medical University of Vienna. Started Sep 2013; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT02511535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02511535.